Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

    August 2011 in “ Journal of The American Academy of Dermatology ”
    Salvador Arias-Santiago, Miguel Angel Arrabal-Polo, Agustín Buendía-Eisman … Salvio Serrano Ortega
    Studysummary This study found that men with early-onset androgenetic alopecia had significantly larger prostate volumes and lower urinary flow rates compared to healthy controls, suggesting a possible link between AGA and prostate-related urinary symptoms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 21

    1. Sex Hormone–Binding Globulin and Risk of Hyperglycemia in Patients With Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    2. Lipid Levels in Women with Androgenetic Alopecia International Journal of Dermatology · 2010
    3. Androgenetic Alopecia and Cardiovascular Risk Factors in Men and Women: A Comparative Study Journal of The American Academy of Dermatology · 2010
    4. Male Androgenetic Alopecia and Cardiovascular Risk Factors: A Case-Control Study Actas Dermo-Sifiliográficas · 2010
    5. Does D Matter? The Role of Vitamin D in Hair Disorders and Hair Follicle Cycling Dermatology Online Journal · 2010
    6. A Comparative Study of Dyslipidemia in Men and Women with Androgenic Alopecia Acta dermato-venereologica · 2010
    7. Hypertension and Aldosterone Levels in Women with Early-Onset Androgenetic Alopecia British Journal of Dermatology · 2009
    8. Elevated Aldosterone Levels in Patients with Androgenetic Alopecia British Journal of Dermatology · 2009
    9. Does Degree of Baldness Influence Vitamin D Status? Medical Journal of Australia · 2008
    10. Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels The Aging Male · 2008
    11. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    12. Protection Against Chemotherapy-Induced Alopecia Pharmaceutical Research · 2006
    13. The Preventive Effect of Vitamin D3 on Radiation-Induced Hair Toxicity in a Rat Model Life sciences · 2005
    14. Patients With a Large Prostate Show a Higher Prevalence of Androgenetic Alopecia The Journal of Urology · 2005
    15. Patients With a Large Prostate Show a Higher Prevalence of Androgenetic Alopecia Archives of Dermatological Research · 2004
    16. Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors British Journal of Dermatology · 2003
    17. Hormonal Treatment for Male-Pattern Hair Loss: Implications for Cancer of the Prostate BJUI · 2002
    18. Risk Factors for Prostate Cancer: A Case-Control Study in Greece International Journal of Cancer · 1999
    19. Association of Benign Prostatic Hyperplasia with Male Pattern Baldness Urology · 1998
    20. The Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients With Male Pattern Baldness The Journal of Clinical Endocrinology and Metabolism · 1994
    21. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992